Xiaoyun Si
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaoyun Si has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Haijun Guo
The Affiliated Hospital of Guizhou Medical University, Guiyang, China
4 shared publicationsNa Deng
The Affiliated Hospital of Guizhou Medical University, Guiyang, China
4 shared publicationsYingying Wei
The Affiliated Hospital of Guizhou Medical University, Guiyang, China
4 shared publicationsFujia Xu
Guizhou Medical University, No. 9 Beijing Road, Guiyang, 550004, Guizhou Province, China
3 shared publicationsLiwei You
The Affiliated Hospital of Guizhou Medical University, Guiyang, China
3 shared publicationsSihan Luo
Guizhou Medical University, No. 9 Beijing Road, Guiyang, 550004, Guizhou Province, China
3 shared publications
Latest Publications
- 18 August 2026
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 57 (5) , 275
GLSP ameliorates monocrotaline-induced pulmonary arterial hypertension through inhibition of the PI3K/AKT and MAPK signaling pathways
Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling and right heart dysfunction, driven largely by excessive proliferation of pulmonary arterial smooth muscle cells (PASMCs). The PI3K/AKT and MAPK signaling pathways are key regulators of this aberrant proliferation. This study investigated whether Ganoderma lucidum spore powder (GLSP), a traditional Chinese medicine with cardiovascular protective effects, ameliorates PAH through modulation of these pathways. In vivo, GLSP administration to monocrotaline (MCT)-induced PAH rats significantly reduced mean pulmonary arterial pressure and right ventricular systolic pressure, attenuated pulmonary vascular wall thickening and fibrosis, and improved right ventricular function, accompanied by suppression of PI3K/AKT and MAPK phosphorylation. In vitro, GLSP reversed PDGFBB-induced PASMC proliferation, migration, and activation of PI3K/AKT and MAPK signaling. Network pharmacology and molecular docking further revealed that GLSP components stably bind to AKT1, SRC, PIK3CA, HSP90AA1, and ESR1—key nodes within these pathways. Our findings, from both in vivo and in vitro experiments, demonstrate that GLSP ameliorates MCT-induced PAH and pulmonary vascular remodeling by inhibiting aberrant PASMC proliferation and migration via suppression of the PI3K/AKT and MAPK signaling axes, highlighting GLSP as a promising therapeutic candidate for PAH. Graphical abstract
- 18 August 2026
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 57 (5) , 275
GLSP ameliorates monocrotaline-induced pulmonary arterial hypertension through inhibition of the PI3K/AKT and MAPK signaling pathways
Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling and right heart dysfunction, driven largely by excessive proliferation of pulmonary arterial smooth muscle cells (PASMCs). The PI3K/AKT and MAPK signaling pathways are key regulators of this aberrant proliferation. This study investigated whether Ganoderma lucidum spore powder (GLSP), a traditional Chinese medicine with cardiovascular protective effects, ameliorates PAH through modulation of these pathways. In vivo, GLSP administration to monocrotaline (MCT)-induced PAH rats significantly reduced mean pulmonary arterial pressure and right ventricular systolic pressure, attenuated pulmonary vascular wall thickening and fibrosis, and improved right ventricular function, accompanied by suppression of PI3K/AKT and MAPK phosphorylation. In vitro, GLSP reversed PDGFBB-induced PASMC proliferation, migration, and activation of PI3K/AKT and MAPK signaling. Network pharmacology and molecular docking further revealed that GLSP components stably bind to AKT1, SRC, PIK3CA, HSP90AA1, and ESR1—key nodes within these pathways. Our findings, from both in vivo and in vitro experiments, demonstrate that GLSP ameliorates MCT-induced PAH and pulmonary vascular remodeling by inhibiting aberrant PASMC proliferation and migration via suppression of the PI3K/AKT and MAPK signaling axes, highlighting GLSP as a promising therapeutic candidate for PAH. Graphical abstract
- 15 July 2025
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 56 (4) , 230
Pannexin1 via P2rx7/amphiregulin contributes to cardiac fibrosis post myocardial infarction
The primary pathological mechanism underlying ventricular remodeling and cardiac dysfunction following myocardial infarction (MI) is predominantly mediated by cardiomyocyte apoptosis. Pannexin1 (PANX1) channels, which open during apoptosis, facilitate the release of ATP from dying cells. However, the functional significance of PANX1 in mediating cardiomyocyte apoptosis and its contribution to myocardial infarction progression remain to be fully elucidated. To investigate the regulatory role of PANX1 in cardiomyocyte apoptosis following MI and elucidate its underlying molecular mechanisms. We conducted both in vivo and vitro studies. In vivo, we observed a significant elevation of PANX1 expression levels in post-MI mice, which facilitated macrophage recruitment and subsequently triggered upregulation of amphiregulin(AREG). In vitro, HL-1 cells exposure to hypoxia/reoxygenation (H/R) induced apoptosis, accompanying with the upregulation of PANX1, enhanced extracellular ATP release. And these alterations promoted the recruitment of RAW264.7 cells, subsequently elevating AREG levels. These effects were mitigated by the knockdown of PANX1. To confirm PANX1's role in MI hearts, AAV-9-PANX1-RNAi and negative control vectors were administered into the hearts of mice. Over 28 days post-MI, PANX1 knockdown significantly enhanced cardiac function and attenuated myocardial fibrosis. Our findings reveal that PANX1 plays a crucial role in facilitating a link between apoptotic cardiomyocyte and macrophage, contributing to modulate myocardial fibrosis and cardiac dysfunctional recovery post-MI via the AREG. Furthermore, the PANX1/P2rx7/AREG pathway is essential for facilitating a link between apoptotic cardiomyocytes and macrophages in mice following MI.
- 15 July 2025
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 56 (4) , 230
Pannexin1 via P2rx7/amphiregulin contributes to cardiac fibrosis post myocardial infarction
The primary pathological mechanism underlying ventricular remodeling and cardiac dysfunction following myocardial infarction (MI) is predominantly mediated by cardiomyocyte apoptosis. Pannexin1 (PANX1) channels, which open during apoptosis, facilitate the release of ATP from dying cells. However, the functional significance of PANX1 in mediating cardiomyocyte apoptosis and its contribution to myocardial infarction progression remain to be fully elucidated. To investigate the regulatory role of PANX1 in cardiomyocyte apoptosis following MI and elucidate its underlying molecular mechanisms. We conducted both in vivo and vitro studies. In vivo, we observed a significant elevation of PANX1 expression levels in post-MI mice, which facilitated macrophage recruitment and subsequently triggered upregulation of amphiregulin(AREG). In vitro, HL-1 cells exposure to hypoxia/reoxygenation (H/R) induced apoptosis, accompanying with the upregulation of PANX1, enhanced extracellular ATP release. And these alterations promoted the recruitment of RAW264.7 cells, subsequently elevating AREG levels. These effects were mitigated by the knockdown of PANX1. To confirm PANX1's role in MI hearts, AAV-9-PANX1-RNAi and negative control vectors were administered into the hearts of mice. Over 28 days post-MI, PANX1 knockdown significantly enhanced cardiac function and attenuated myocardial fibrosis. Our findings reveal that PANX1 plays a crucial role in facilitating a link between apoptotic cardiomyocyte and macrophage, contributing to modulate myocardial fibrosis and cardiac dysfunctional recovery post-MI via the AREG. Furthermore, the PANX1/P2rx7/AREG pathway is essential for facilitating a link between apoptotic cardiomyocytes and macrophages in mice following MI.
- 7 June 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 351, 120080
Scoparone alleviates aortic aneurysm formation by inhibiting smooth muscle cell phenotypic switching and inflammation via mTOR suppression
- 7 June 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 351, 120080
Scoparone alleviates aortic aneurysm formation by inhibiting smooth muscle cell phenotypic switching and inflammation via mTOR suppression
- 29 December 2023
- Published by Elsevier in European Journal of Pharmacology
- Vol. 965, 176307
Trimethylamine N-oxide promotes abdominal aortic aneurysm by inducing vascular inflammation and vascular smooth muscle cell phenotypic switching
- 29 December 2023
- Published by Elsevier in European Journal of Pharmacology
- Vol. 965, 176307
Trimethylamine N-oxide promotes abdominal aortic aneurysm by inducing vascular inflammation and vascular smooth muscle cell phenotypic switching